Xact Kapitalforvaltning’s TherapeuticsMD TXMD Stock Holding History

Xact Kapitalforvaltning’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$32K	Hold	608	–	–	﹤0.01%	1308
2019 Q4	$73K	Hold	608	–	–	﹤0.01%	1407
2019 Q3	$111K	Hold	608	–	–	﹤0.01%	1417
2019 Q2	$80K	Hold	608	–	–	﹤0.01%	1435
2019 Q1	$148K	Sell	608 -28	-4%	-$7.41K	﹤0.01%	1416
2018 Q4	$121K	Hold	636	–	–	﹤0.01%	1479
2018 Q3	$208K	Hold	636	–	–	﹤0.01%	1514
2018 Q2	$198K	Hold	636	–	–	﹤0.01%	1553
2018 Q1	$155K	Buy	636 +312	+96%	+$87.5K	﹤0.01%	1510
2017 Q4	$98K	Buy	+324	New	+$90.2K	﹤0.01%	1316

Other funds holding TXMD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Xact Kapitalforvaltning's TXMD Position: Q1 2020 in Review

Xact Kapitalforvaltning held its TherapeuticsMD (TXMD) position steady in Q1 2020 at 608 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #1308.

Xact Kapitalforvaltning first reported a position in TXMD in Q4 2017 and has held it in 10 quarters since. The position peaked at $208K in Q3 2018. 143 funds tracked by Wall St. Rank hold TXMD as of Q1 2020.

Xact Kapitalforvaltning held 608 shares of TherapeuticsMD worth $32K as of Q1 2020.
Xact Kapitalforvaltning left its TherapeuticsMD share count unchanged in Q1 2020.
TherapeuticsMD made up ﹤0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1308 holding.
Xact Kapitalforvaltning first reported a position in TherapeuticsMD in Q4 2017 and has held it in 10 quarters since.
Xact Kapitalforvaltning's TherapeuticsMD position peaked at $208K in Q3 2018.
143 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.